David Ritchie

ORCID: 0000-0003-4816-113X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Cancer Incidence and Screening
  • Cervical Cancer and HPV Research
  • Nutrition, Genetics, and Disease
  • Patient-Provider Communication in Healthcare
  • Colorectal Cancer Screening and Detection
  • School Health and Nursing Education
  • Technology and Data Analysis
  • Health Systems, Economic Evaluations, Quality of Life
  • Economic and Financial Impacts of Cancer
  • BRCA gene mutations in cancer
  • Health Literacy and Information Accessibility
  • Mobile Health and mHealth Applications
  • Public Health Policies and Education
  • Electromagnetic Launch and Propulsion Technology
  • Air Quality and Health Impacts
  • Swearing, Euphemism, Multilingualism
  • Non-Destructive Testing Techniques
  • Grief, Bereavement, and Mental Health
  • Target Tracking and Data Fusion in Sensor Networks
  • Behavioral Health and Interventions
  • Environmental Justice and Health Disparities
  • Health, Environment, Cognitive Aging
  • Higher Education Governance and Development
  • Health Policy Implementation Science
  • Maritime Transport Emissions and Efficiency

European CanCer Organisation
2017-2023

Centre International de Recherche sur le Cancer
2023

University of Antwerp
2018-2022

European Cancer Prevention
2021

Province of Antwerp
2018

Abstract The age‐standardised incidence of cervical cancer in Europe varies widely by country (between 3 and 25/100000 women‐years) 2018. Human papillomavirus (HPV) vaccine coverage is low countries with the highest screening performance heterogeneous among European countries. A broad group delegates scientific professional societies organisations endorse principles WHO call to eliminate as a public health problem, also Europe. All nations should, 2030, reach at least 90% HPV girls age 15...

10.1002/ijc.33189 article EN cc-by-nc International Journal of Cancer 2020-07-08

Abstract Background The MyPeBS study is an ongoing randomised controlled trial testing whether a risk-stratified breast cancer screening strategy non-inferior, or eventually superior, to standard age-based at reducing incidence of stage 2 more cancers. This large European Commission-funded initiative aims include 85,000 women aged 40 70 years, without prior and not previously identified high risk in six countries (Belgium, France, Italy, Israel, Spain, UK). A specific work package within...

10.1186/s12885-022-09484-6 article EN cc-by BMC Cancer 2022-05-06

Abstract Background To evaluate the acceptability of a risk-based breast cancer screening (BCS) strategy among professionals involved in MyPeBS study 6 countries. Methods After qualitative interviews, questionnaire was built with Delphi method: to professionals’ basic understanding, satisfaction and reactions each stage trial, opinions on BCS its future. The distributed by emailing 698 investigators, who forwarded it all categories trial recruitment (physicians, medical secretaries, nurses,...

10.1186/s12885-025-13848-z article EN cc-by BMC Cancer 2025-03-15

Abstract Background This study aimed to investigate the status of cervical cancer screening (CCS) implementation in Europe by investigating national or regional policies towards broadening coverage CCS amongst vulnerable subgroups population at high risk for CC. Methods A web-based survey was conducted between September 2021 and February 2022 with programme managers experts identify rank six considered most CC map existing that addressed sub-groups risk. Results total 31 responses were...

10.1093/eurpub/ckad055 article EN cc-by-nc European Journal of Public Health 2023-04-12

Cervical cancer remains a significant public health concern in Europe. Effective introduction and scaling up of human papillomavirus (HPV) detection-based cervical screening (CCS) requires systematic assessment systems capacity. However, there is no validated capacity methodology for CCS programmes, especially European contexts. Addressing this gap, our study introduces an innovative adaptable protocol evaluating the programmes across varying system settings. Our research team developed...

10.1186/s12961-024-01190-y article EN cc-by-nc-nd Health Research Policy and Systems 2024-08-12

The European Code against Cancer (ECAC) informs the public on steps to take reduce their cancer risk. Despite over three decades of promotion, no systematic evaluation its impact has yet been carried out. This study aimed address gap in knowledge regarding ECAC. An online survey targeting adults general population was conducted and analysed by age, gender, country, both descriptive mutually adjusted logistic regression analyses. Additionally, semi-structured interviews with health promotion...

10.1016/j.canep.2021.101898 article EN cc-by-nc-nd Cancer Epidemiology 2021-02-21

Abstract Background Participation in mammography screening comes with harms alongside benefits. Information about provided to women should convey this information yet concerns persist its effect on participation. This study addressed factors that may influence the intention screen once a woman has been informed benefits and of Methods A cross-sectional survey from five countries (Belgium, France, Italy, Spain, United Kingdom) was performed January 2021. The contained statement regarding...

10.1186/s13690-022-00902-6 article EN cc-by Archives of Public Health 2022-05-23

As part of the third European Commission's Joint Action on Cancer (Innovative Partnership for Against Cancer, iPAAC), International Agency Research (IARC) was commissioned to produce a report recommendations sustain and monitor future updates Code (ECAC). A co-creational consultation process, including virtual workshop, carried out. More than 100 experts in cancer prevention, public health, communication representatives authorities provided input scope editions ECAC, updating scientific...

10.1016/j.canep.2021.101933 article EN cc-by-nc-nd Cancer Epidemiology 2021-04-07

Background Mobile health technologies, underpinned by scientific evidence and ethical standards, exhibit considerable promise potential in actively engaging consumers patients while also assisting care providers delivering cancer prevention services. The WASABY mobile app was conceived as an innovative, evidence-based tool aimed at disseminating age-appropriate messages from the European Code Against Cancer (ECAC) to adolescents across Europe. Objective This study aims assess outcomes of...

10.2196/48040 article EN cc-by JMIR Cancer 2023-11-28

Cancer is a major public health concern in the European Union (EU). There were 2.7 million new cancer cases and 1.3 deaths EU; of them, around 40% could be prevented. Primary prevention most cost-effective long-term strategy for control. The Code Against (ECAC, 4 th edition) education tool aimed at raising awareness about evidence-based actions among EU citizens. ECAC describes 12 ways individuals can reduce their risk. Awareness (4 ed.) was low (2–21%) and, therefore, efforts are needed to...

10.5603/njo.96724 article EN cc-by-nc-nd Nowotwory Journal of Oncology 2023-09-18

Abstract Introduction The European Code against Cancer (ECAC) informs the public on steps to take reduce their cancer risk. Despite over three decades of promotion, no systematic evaluation its impact has yet been carried out. This study aimed address gap in knowledge regarding ECAC. Methods An online survey targeting adults general population was conducted and analysed by age, gender, country, both descriptive mutually adjusted logistic regression analyses. Additionally, semi-structured...

10.1093/eurpub/ckab164.231 article EN European Journal of Public Health 2021-10-01

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Ritchie D. Contribution of cancer leagues to the promotion and organisation screening programmes. Journal Health Inequalities. 2017;3(2):157-161. doi:10.5114/jhi.2017.74210. APA Ritchie, (2017). Inequalities, 3(2), 157-161. https://doi.org/10.5114/jhi.2017.74210 Chicago David. 2017. "Contribution programmes". Inequalities 3 (2): Harvard pp.157-161. MLA programmes." vol. 3, no. 2, 2017, pp. Vancouver

10.5114/jhi.2017.74210 article EN Journal of Health Inequalities 2017-01-01

assurance as well independent double reading of all suspicious findings and a random sample CT scans.Results: Almost 20.000 individuals with OAE in Germany meet the eligibility criteria for LD-HRCT.In feasibility study, 730 out 1220 (59.8%) who were counselled LD-HRCT by program physicians participated initial screening.In second regular screening round 12 months later, participation rate was somewhat lower (47.2%).More detailed outcome parameters such detection stage lung cancer, false...

10.1093/eurpub/cky214.250 article EN European Journal of Public Health 2018-11-01
Coming Soon ...